Literature DB >> 20924107

Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells.

Maria Rosa Lidonnici1, Alessandra Audia, Angela Rachele Soliera, Marco Prisco, Giovanna Ferrari-Amorotti, Todd Waldron, Nick Donato, Ying Zhang, Robert V Martinez, Tessa L Holyoake, Bruno Calabretta.   

Abstract

Ectopic expression of CAAT/enhancer binding protein α (C/EBPα) in p210BCR/ABL-expressing cells induces granulocytic differentiation, inhibits proliferation, and suppresses leukemogenesis. To dissect the molecular mechanisms underlying these biological effects, C/EBPα-regulated genes were identified by microarray analysis in 32D-p210BCR/ABL cells. One of the genes whose expression was activated by C/EBPα in a DNA binding-dependent manner in BCR/ABL-expressing cells is the transcriptional repressor Gfi-1. We show here that C/EBPα interacts with a functional C/EBP binding site in the Gfi-1 5'-flanking region and enhances the promoter activity of Gfi-1. Moreover, in K562 cells, RNA interference-mediated downregulation of Gfi-1 expression partially rescued the proliferation-inhibitory but not the differentiation-inducing effect of C/EBPα. Ectopic expression of wild-type Gfi-1, but not of a transcriptional repressor mutant (Gfi-1P2A), inhibited proliferation and markedly suppressed colony formation but did not induce granulocytic differentiation of BCR/ABL-expressing cells. By contrast, Gfi-1 short hairpin RNA-tranduced CD34(+) chronic myeloid leukemia cells were markedly more clonogenic than the scramble-transduced counterpart. Together, these studies indicate that Gfi-1 is a direct target of C/EBPα required for its proliferation and survival-inhibitory effects in BCR/ABL-expressing cells. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924107      PMCID: PMC2955805          DOI: 10.1158/0008-5472.CAN-10-1667

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

Review 1.  C/EBPalpha mutations in acute myeloid leukaemias.

Authors:  Claus Nerlov
Journal:  Nat Rev Cancer       Date:  2004-05       Impact factor: 60.716

2.  Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.

Authors:  Hui Zeng; Raif Yücel; Christian Kosan; Ludger Klein-Hitpass; Tarik Möröy
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

3.  Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.

Authors:  Karen Keeshan; Giorgia Santilli; Francesca Corradini; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

4.  The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation.

Authors:  J J Westendorf; C M Yamamoto; N Lenny; J R Downing; M E Selsted; S W Hiebert
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

5.  Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C/EBPalpha expression.

Authors:  Rui Zheng; Alan D Friedman; Mark Levis; Li Li; Edward G Weir; Donald Small
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

6.  The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells.

Authors:  Francesco D'Alo'; Lisa M Johansen; Erik A Nelson; Hanna S Radomska; Erica K Evans; Pu Zhang; Claus Nerlov; Daniel G Tenen
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

7.  The CCAAT enhancer-binding protein alpha (C/EBPalpha) requires a SWI/SNF complex for proliferation arrest.

Authors:  Christine Müller; Cornelis F Calkhoven; Xiaojing Sha; Achim Leutz
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

8.  Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells.

Authors:  Hanno Hock; Melanie J Hamblen; Heather M Rooke; Jeffrey W Schindler; Shireen Saleque; Yuko Fujiwara; Stuart H Orkin
Journal:  Nature       Date:  2004-09-29       Impact factor: 49.962

9.  CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors.

Authors:  H S Radomska; C S Huettner; P Zhang; T Cheng; D T Scadden; D G Tenen
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

10.  Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation.

Authors:  Jan Jacob Schuringa; Ki Young Chung; Giovanni Morrone; Malcolm A S Moore
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more
  16 in total

1.  Role of Erk1/2 signaling in the regulation of neutrophil versus monocyte development in response to G-CSF and M-CSF.

Authors:  Nan Hu; Yaling Qiu; Fan Dong
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells.

Authors:  Valentina Fragliasso; Yuri Chiodo; Giovanna Ferrari-Amorotti; Angela Rachele Soliera; Gloria Manzotti; Sara Cattelani; Olivia Candini; Giulia Grisendi; Jenny Vergalli; Samanta Antonella Mariani; Clara Guerzoni; Bruno Calabretta
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

Review 3.  Selecting the best frontline treatment in chronic myeloid leukemia.

Authors:  Musa Yilmaz; Yasmin Abaza; Elias Jabbour
Journal:  Curr Hematol Malig Rep       Date:  2015-06       Impact factor: 3.952

4.  Neutrophil Elastase Regulates Emergency Myelopoiesis Preceding Systemic Inflammation in Diet-induced Obesity.

Authors:  Jun-Yuan Huang; Qiong Lin Zhou; Chun-Hong Huang; Ye Song; Andria G Sharma; Zhangping Liao; Kavin Zhu; Miles W Massidda; Ryan R Jamieson; Jun-Yuan Zhang; Daniel G Tenen; Zhen Y Jiang
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

5.  SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.

Authors:  Daniel Andrade; Matthew Velinder; Jason Singer; Luke Maese; Diana Bareyan; Hong Nguyen; Mahesh B Chandrasekharan; Helena Lucente; David McClellan; David Jones; Sunil Sharma; Fang Liu; Michael E Engel
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

Review 6.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

7.  Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1.

Authors:  A R Soliera; S A Mariani; A Audia; M R Lidonnici; S Addya; G Ferrari-Amorotti; S Cattelani; G Manzotti; V Fragliasso; L Peterson; G Perini; T L Holyoake; B Calabretta
Journal:  Leukemia       Date:  2012-01-30       Impact factor: 11.528

8.  Hierarchical decomposition of dynamically evolving regulatory networks.

Authors:  Ahmet Ay; Dihong Gong; Tamer Kahveci
Journal:  BMC Bioinformatics       Date:  2015-05-15       Impact factor: 3.169

9.  Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.

Authors:  Ou Ma; SunHwa Hong; Hong Guo; Gabriel Ghiaur; Alan D Friedman
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

10.  Lymphoid progenitor cells from childhood acute lymphoblastic leukemia are functionally deficient and express high levels of the transcriptional repressor Gfi-1.

Authors:  Jessica Purizaca; Adriana Contreras-Quiroz; Elisa Dorantes-Acosta; Eduardo Vadillo; Lourdes Arriaga-Pizano; Silvestre Fuentes-Figueroa; Horacio Villagomez-Barragán; Patricia Flores-Guzmán; Antonio Alvarado-Moreno; Hector Mayani; Isaura Meza; Rosaura Hernandez; Sara Huerta-Yepez; Rosana Pelayo
Journal:  Clin Dev Immunol       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.